Skip to content

To explore the effect of moxibustion Guanyuan acupoint on primary dysmenorrhea and the mechanism of neuroplasticity based on TMS-EEG

To explore the effect of moxibustion Guanyuan acupoint on primary dysmenorrhea and the mechanism of neuroplasticity based on TMS-EEG

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087167
Enrollment
Unknown
Registered
2024-07-22
Start date
2024-07-24
Completion date
Unknown
Last updated
2024-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary dysmenorrhea

Interventions

moxibustion Guanyuan acupoint group :moxibustion Guanyuan acupoint
Control group:none

Sponsors

Affiliated Hospital of Hangzhou Normal University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Patients aged 18-35 years met the criteria for primary dysmenorrhea: lower abdominal pain before and after menstruation, or more than 3 consecutive times. Accompanied by lumbar acid or other discomfort. (1) Cyclical lower abdominal pain occurs before and after menstruation or during menstruation, which can be accompanied by lumbar acid or other discomfort. (2) No obvious organic lesions were found in the reproductive system, and secondary dysmenorrhea caused by endometriosis and adenomyopathy was excluded. (3) After receiving treatment, no Chinese medicine or other pain-relieving drugs can be taken before menstruation, and corresponding treatment measures can be taken when the menstrual pain is unbearable. (4) Patients who voluntarily participate in this study.

Exclusion criteria

Exclusion criteria: (1) Patients with irregular periods; (2) Patients who refuse to stop taking the drug; (3) Patients with serious primary diseases such as cardiovascular and cerebrovascular, liver, kidney and hematopoietic system; (4) Unable to accept TMS evaluation (e.g., cardiac pacemaker); (5) severe mental illness due to various reasons, unable to sit for assessment and treatment; (6) Patients with other serious diseases such as malignant tumors; (7) Metal implantation of the latter; People with a history of epilepsy; (8) Patients who have received craniocerebral surgery.

Design outcomes

Primary

MeasureTime frame
Dysmenorrhea symptom score;

Secondary

MeasureTime frame
TMS-EEG and EEG;

Countries

China

Contacts

Public ContactJiqing He

Affiliated Hospital of Hangzhou Normal University

hejiqing8d@163.com+86 158 2411 7292

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026